JLK inhibitors: isocoumarin compounds as putative probes to selectively target the gamma-secretase pathway.
Checler F, Alves da Costa C, Ayral E, Andrau D, Dumanchin C, Farzan M, Hernandez JF, Martinez J, Lefranc-Jullien S, Marambaud P, Pasini A, Petit A, Phiel C, Robert P, St George-Hyslop P, Wilk S.
Checler F, et al. Among authors: lefranc jullien s.
Curr Alzheimer Res. 2005 Jul;2(3):327-34. doi: 10.2174/1567205054367874.
Curr Alzheimer Res. 2005.
PMID: 15974898
Review.